Moody Lynn & Lieberson, LLC Bristol Myers Squibb CO Transaction History
Moody Lynn & Lieberson, LLC
- $1.48 Billion
- Q1 2025
A detailed history of Moody Lynn & Lieberson, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 341,788 shares of BMY stock, worth $16.7 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
341,788
Previous 157,930
116.42%
Holding current value
$16.7 Million
Previous $8.93 Million
133.37%
% of portfolio
1.41%
Previous 0.58%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.34 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.74 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.27 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.63 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.24 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...